Welcome to Markets Desk, your midday read on what's moving markets and the world.
Treasury yields are back in focus, and bond investors are feeling the pressure. As yields climb, existing bond prices fall, and that math is starting to bleed into equities. Higher baseline rates compress valuations, particularly for growth stocks, and remind investors that duration risk is very real in this environment.
Shifting to the dividend space, AbbVie and Pfizer are drawing renewed attention from income-focused investors navigating that same volatility. Both names carry meaningful yields and defensive characteristics, but their underlying pipelines tell very different stories heading into the back half of the year, making the comparison worth a serious look right now.
And on the ground in Ukraine, a remarkable development in modern warfare. A Ukrainian army unit says it successfully air-dropped explosive-laden ground robots behind Russian lines, using drones to deploy autonomous machines miles into enemy territory. The operation, called Vivaldi, remains largely classified, but officials say it helped retake ground and signals a significant evolution in how this war is being fought.
That's the tape. Markets Desk, signing off the floor.
